 |

| June 23, 2008 Issue |
Volume 70, Number 25 |
Lead Stories for this Issue
Medical Schools Take Stand Against Industry Gifts While AMA Sits Out DebatePediatric Psoriasis Patients’ Access To Enbrel Is Factor In Committee NodWith A Novel Pipeline, Pfizer Tries A New Oncology Business Unit Too
Go to this Issue >>
|
| June 16, 2008 Issue |
Volume 70, Number 24 |
Lead Stories for this Issue
From Playing It Safe To All-In: Genentech Takes Risks With Oncology PipelineNovartis’ Analytic Capabilities A Key Part Of WellPoint Health IT PilotHypertensives May Get Class Outcome Labels; Industry Wary Of Broad Efficacy
Go to this Issue >>
|
| June 9, 2008 Issue |
Volume 70, Number 23 |
Lead Stories for this Issue
AVADO Presented At ASCO; But After The Fanfare, What Does It Signify?FDA Chief Scientist Torti’s Plan For First 100 Days Centers On ExcellenceOff-Label Dissemination Keeps FDA Stuck Between Prosecutors And Firms
Go to this Issue >>
|
|
 |
|
 |